Answers are grounded in this paper and cite their sources.
Epigenetic mechanisms—DNA methylation, histone modifications, non-coding RNA activity, N6-methyladenosine (m6A) RNA modification and ATP-dependent chromatin remodelling—regulate gene expression without altering the underlying DNA sequence, and they respond to environmental and pharmacological stimuli. Traditional Chinese Medicine (TCM) selects multi-botanical-drug preparations according to syndrome patterns (zheng) rather than biomedical disease categories, and epigenetics has been proposed as a framework within which the action of such preparations might be examined. We reviewed the literature as two related but distinct evidence streams: 76 study-level reports covering 59 distinct interventions, comprising 26 multi-botanical-drug formulas, seven extracts of a single botanical drug, one metabolite–botanical drug combination, 41 isolated plant metabolites or metabolite mixtures, and one derived peptide. Because ConPhyMP addresses plant material and its extracts, we applied it only to the 34 botanical-drug preparations, and audited the isolated metabolites separately for provenance and for specificity to the Chinese materia medica. Botanical authentication, drug-to-extract ratios, chromatographic fingerprints and marker-metabolite quantification were available for a minority of the 34 preparations, and no study compared two batches of the same preparation. On a nine-level evidence scale, 59 of 76 reports reached grade 5 (perturbational dependence) and one reached grade 9 (randomised trial); none reached grade 6, at which an epigenetic change is shown to mediate a phenotypic effect. Six of the most frequently studied metabolites—curcumin, resveratrol, epigallocatechin-3-gallate, quercetin, luteolin and kaempferol—are major metabolites of cosmopolitan food plants, which limits how far their effects can be generalised to TCM practice. Epigenetics remains a plausible and testable framework for TCM botanical drugs, and advancing it will depend on ConPhyMP-compliant reporting and on formula-level designs that can compare a preparation with its individual metabolites.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: